Inhibition of recombinant sphingosine kinases by novel inhibitors of microbial origin, F-12509A and B-5354c.
Kono
Keita
K
Pharmacology and Molecular Biology Research Laboratories, Research Institute, Sankyo Co., Ltd., Shinagawa, Tokyo, Japan.
Sugiura
Masako
M
Kohama
Takafumi
T
D010129:4-Aminobenzoic Acid / Q000494:pharmacology*; D016227:Benzoquinones / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D006801:Humans; D007700:Kinetics; D017853:Phosphotransferases (Alcohol Group Acceptor) / Q000037:antagonists & inhibitors*; D062366:para-Aminobenzoates; D000099157:Sphingosine Kinase
D010129:4-Aminobenzoic Acid; D016227:Benzoquinones; D004791:Enzyme Inhibitors; D017853:Phosphotransferases (Alcohol Group Acceptor); D062366:para-Aminobenzoates; D000099157:Sphingosine Kinase; C416812:B 5354c; C411675:F 12509A